ClinicalTrials.gov
ClinicalTrials.gov Menu

Minimal Extracorporeal Circuits (MECC) in Cardiac Surgery Procedures (MECC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01306903
Recruitment Status : Completed
First Posted : March 2, 2011
Last Update Posted : June 4, 2013
Sponsor:
Information provided by (Responsible Party):
Arndt-H. Kiessling, Johann Wolfgang Goethe University Hospital

Brief Summary:

The standard heart-lung machine is a major trigger of systemic inflammatory reactions, hemodilution, coagulopathy or organ failure. The strict reduction of blood-artificial surface and blood-air contact might represent meaningful improvements of the extracorporeal technology with respect to organ preservation.

The aim of this study is the evaluation of potential differences between a minimal extracorporeal circuit (MECC) and a conventional cardiopulmonary bypass (MOPS) system.


Condition or disease Intervention/treatment Phase
Postoperative Bloodloss Device: MECC Device: MOPS Device: Super MOPS Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 68 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Minimal Extracorporeal Circuits (MECC) in Cardiac Surgery Procedures
Study Start Date : March 2011
Actual Primary Completion Date : June 2013
Actual Study Completion Date : June 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding

Arm Intervention/treatment
Experimental: MECC
Minimal extracorporeal circuit
Device: MECC
Minimized extracorporeal circulation

Placebo Comparator: MOPS Device: MOPS
Modified and optimized perfusion system Frankfurt

Placebo Comparator: Super MOPS Device: Super MOPS
Super modified and optimized perfusion system Frankfurt




Primary Outcome Measures :
  1. Bloodloss [ Time Frame: postoperative ]
    Count of red blood packages



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • extracorporeal circulation
  • age > 18 years old

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01306903


Locations
Germany
Goethe University Hospital
Frankfurt, Germany, 60590
Sponsors and Collaborators
Johann Wolfgang Goethe University Hospital
Investigators
Principal Investigator: Arndt H Kiessling, MD Cooperative Weichteilsarkom Study Group

Additional Information:
Responsible Party: Arndt-H. Kiessling, PI, Johann Wolfgang Goethe University Hospital
ClinicalTrials.gov Identifier: NCT01306903     History of Changes
Other Study ID Numbers: Mini-ECC001AHK
First Posted: March 2, 2011    Key Record Dates
Last Update Posted: June 4, 2013
Last Verified: June 2013

Keywords provided by Arndt-H. Kiessling, Johann Wolfgang Goethe University Hospital:
Minimizing Cardiopulmonary Bypass MECC damage organ failure

Additional relevant MeSH terms:
Postoperative Hemorrhage
Hemorrhage
Pathologic Processes
Postoperative Complications